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Cystoisospora belli is an intestinal Apicomplexan parasite associated with diarrheal illness 
and disseminated infections in humans, mainly immunocompromised individuals such as 
those living with the human immunodeficiency virus (HIV) or acquired immunodeficiency 
syndrome (AIDS). An irregular administration of highly active antiretroviral therapy (HAART) 
in HIV patients may increase the risk of opportunistic infections like cystoisosporiasis.
We describe here a case of C. belli infection in a Colombian HIV patient with chronic 
gastrointestinal syndrome and poor adherence to HAART. His clinical and parasitological 
cure was achieved with trimethoprim-sulfamethoxazole treatment. Although a reduction in 
the number of C. belli cases has been observed since the use of HAART, this parasite still 
has to be considered as a differential diagnosis of diarrheal disease in HIV/AIDS patients. 
Effective interventions enhancing adherence to HAART should be included in HIV patient 
care programs.
Keywords: Apicomplexa; diarrhea; HIV; acquired immunodeficiency syndrome; antiretroviral 
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Infección crónica por Cystoisospora belli en un paciente colombiano con HIV y 
cumplimiento deficiente de la terapia antirretroviral de gran actividad
Cystoisospora belli es un parásito intestinal del filo Apicomplexa asociado con 
enfermedades diarreicas e infecciones diseminadas en humanos, principalmente 
en individuos inmunocomprometidos, como aquellos infectados con el virus de la 
inmunodeficiencia humana (HIV) o el síndrome de inmunodeficiencia adquirida (sida). El 
cumplimiento inadecuado de la terapia antirretroviral de gran actividad (TARGA) puede 
aumentar el riego de infecciones oportunistas, incluida la cistoisosporiasis. 
Se describe el caso de infección por C. belli en un paciente colombiano con HIV, 
que presentó un síndrome gastrointestinal crónico e incumplía el tratamiento con la 
TARGA. Después del diagnóstico parasitológico, el paciente fue tratado con trimetoprim-
sulfametoxazol, lográndose la recuperación clínica y la cura parasitológica. Aunque se 
ha observado una reducción en el número de casos de C. belli desde la implementación 
de la TARGA, este parásito aún debe considerarse en el diagnóstico diferencial de las 
enfermedades diarreicas en pacientes con HIV/sida. Los programas de atención deben incluir 
intervenciones efectivas que potencien el cumplimiento de la TARGA en estos pacientes. 
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Cystoisospora belli is an obligate intracellular Apicomplexan parasite from 
the family Sarcocystidae responsible for human cistoisosporiasis, an intestinal 
cosmopolitan infection that is more frequent in tropical and subtropical 
regions (1-3). Although it was originally described in the genus Isospora, the 
identification of morphological, biological, and genetic differences between 
species from nonmammalian and mammalian hosts led to the creation of the 
genus Cystoisospora (4), which includes mammalian species with facultative 
heteroxeny, oocysts containing two sporocysts with four sporozoites each, no 
Stieda bodies in sporocysts, and the ability to produce monozoic tissue cysts 
in intermediate or paratenic hosts (1,5,6).
Cystoisospora belli has a fecal-oral transmission cycle (3). Human hosts 
become infected through the ingestion of sporulated oocysts present in water 
or contaminated food. After consumption, the oocysts excyst in the small bowel 
and release sporozoites which invade enterocytes where the parasite multiplies 
asexually (endodyogeny) and sexually within the parasitophorous vacuole (2,3,7). 
Cystoisospora belli can also infect epithelial cells of bile ducts and gallbladder, 
especially in severely immunocompromised patients. Its life cycle is completed 
by the generation of an immature oocyst via fertilization of a female gamete 
(macrogamont) by a male gamete (microgamont) (2,3,7,8). Oocysts are excreted 
in stool and sporulate in the environment where they can survive for months.
Cystoisospora belli oocysts are generally bell-shaped, their size is 17-
37 x 8-21 µm, and they have a very thin and smooth oocyst wall (3). Some 
sporozoites encyst in extra-intestinal organs (spleen, liver, mediastinal, 
trachea-bronchial, and mesenteric lymph nodes) and in intestinal lamina 
propria, particularly in immunosuppressed humans, producing monozoic 
tissue cysts (2,3,7,9). Until now, paratenic or intermediate hosts have not been 
identified in C. belli’s life cycle.
Cystoisosporiasis is characterized by watery diarrhea, abdominal pain, 
fever, nausea, anorexia, significant weight loss, and may lead to dehydration 
and cachexia (3,7). Eosinophilia, steatorrhea, and the presence of Charcot-
Leyden crystals are also common in C. belli infection (3). Symptoms are more 
severe in patients with immunity alterations, especially AIDS, but also in those 
with organ transplants subjected to immunosuppressive therapy, as well as 
patients with Hodgkin´s disease, leukemia, and HTLV infection, among others 
(2,3,7). Immunocompetent hosts usually develop self-limited watery diarrhea 
and cases are mostly related to travelers from endemic areas. 
Cystoisosporiasis therapy involves supportive treatment (fluid, electrolyte, and 
nutritional support) and antibiotics, trimethoprim-sulfamethoxazole (TMP-SMX) or 
cotrimoxazole, being the drugs of choice (3,8). Recurrence reports are common, 
which makes the infection difficult to eradicate and favoring its chronicity.
Despite its global distribution, C. belli is particularly endemic in tropical 
and subtropical areas from low-income countries in the Caribbean, Central 
and South America, Africa, and South-East Asia (3,10). Prevalence rates 
are significantly higher in HIV-infected patients compared to HIV-negative 
ones with values ranging between 0.4% and 28% (3). Data from endemic 
areas also vary among countries with prevalences ranging from 1.1% to 30% 
in South America (3). Cystoisospora belli epidemiology has been poorly 
evaluated in Colombia; the few studies conducted report prevalence rates 
between 0.06% and 8% in patients living with HIV and children (11-15) (table 
1). Here we describe a case of chronic diarrhea due to C. belli in a Colombian 
patient living with HIV and poor adherence to HAART.
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Case report
We report a 57-year-old heterosexual man diagnosed with HIV nine years 
ago. He has two children and no stable partner and he currently attends a 
care program for people living with HIV. He lives in an urban area of Caucasia 
municipality in Antioquia, Colombia. The town is located 270 Km from 
Medellín, it is 150 meters above sea level, with an average temperature of 
25°C to 32°C and a tropical monsoon climate. The patient works in different 
trades related to auto mechanics. He was admitted to the care program 
on July 3, 2018, and restarted the HIV second-line regimen of zidovudine/
lamivudine/lopinavir/ritonavir (AZT/3TC-LPV/r). 
In the anthropometry evaluation, mild malnutrition (BMI=17.92) was 
reported but no other antecedents or comorbidities, except active smoking. He 
had received vaccination against hepatitis B, influenza, and pneumococcus 
a year earlier. Due to his history of poor adherence to antiretroviral therapy, 
follow-up was established to ensure treatment success. 
He consulted with a four-month history of diarrhea, abdominal distension, 
flatulence, subjective weight loss, rectal bleeding, and hematochezia, but 
no fever. Gastrointestinal symptoms coincided with the start of the HAART. 
Initially, these symptoms were associated with the enhanced protease inhibitor 
included in the highly active antiretroviral therapy cocktail and, therefore, 
appropriate recommendations were given to improve gastrointestinal tolerance 
to these drugs. 
Besides, a parasitological study was requested to identify the infectious 
etiology of the clinical syndrome. Cystoisospora belli oocysts were detected 
by microscopic analysis of direct saline and iodine wet mounts of the patient´s 
stool (figure 1A) along with the modified Ritchie sedimentation method. The 
diagnosis was confirmed by using the Kinyoun stain technique (figure 1B). 
Figure 1. Inmature Cystoisospora belli oocyst with one sporoblast. A. Direct saline wet mount. 
400X. B. Inmature Cystoisospora belli oocyst with one sporoblast. Kinyoun stain, 1.000X. 
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At the time of the diagnosis, the patient´s HIV viral load was <40 copies/
ml and his CD4 T lymphocytes count was 465 cells/mm3. The hematological 
parameters were normal and he was negative for hepatitis C (antibodies) and 
hepatitis B (antigens and antibodies). 
The patient was prescribed trimethoprim/sulfamethoxazole (TMP/SMX) 
DS 160/800 mg every 12 hours for two weeks and then every 24 hours for the 
same period. A full recovery of the gastrointestinal symptoms was achieved 
and the anthropometric data of the patient indicated a eutrophic nutritional 
status (BMI=19.21) and a weight gain of 6 kg since the last control.
Ethical considerations
The study protocol followed the ethical guidelines of the 2013 Declaration 
of Helsinki. All approvals observed the ethical standards set by the Ministry 
of Health of Colombia (Resolution 008430 of 1993). The patient signed an 
informed consent explaining the purposes, benefits, and risks of the study. 
The patient’s data were kept in confidentiality. The Universidad de Antioquia 
Bioethics Committee approved the investigation protocol (official document N° 
17-06-760).
Discussion
Diarrhea is a frequent and often inadequately treated complication in 
people living with HIV, which contributes to the reduced life quality and 
survival of these patients. It is estimated that 50% - 60% of AIDS patients 
have diarrhea at some point during their illness (16) and nearly 90% of them 
in developing countries (17). Hence, the etiology of this symptom should be 
carefully studied to reduce the morbidity and mortality associated. 
Although HAART has significantly reduced the incidence of most 
opportunistic infections, parasite-related diarrhea remains a common problem 
in patients living with HIV, particularly in developing countries where they are 
probably underestimated (10,18). Cystoisospora belli is one of the parasites 
most frequently associated with diarrhea in patients living with HIV. During 
the 90s, C. belli cases were described worldwide, however, in the HAART 
era, cystoisosporiasis cases have concentrated in tropical and subtropical 
areas of developing countries (10). A recent global systematic review and 
meta-analysis of parasite prevalence in patients living with HIV showed a 
heavy burden of Cryptosporidium, microsporidia, and Cystoisospora infection, 
especially in low-income countries and sub-Saharan Africa (10). The few 
studies found in Latin American countries indicate that the epidemiology of 
this parasite is poorly known in our continent.
Here, we present a C. belli infection case associated with chronic 
diarrhea in a Colombian patient from Caucasia municipality where tropical 
monsoon climate facilitates the sporulation of the parasite oocysts and 
their transmission to humans. Additional factors are probably related to an 
increased risk of C. belli infection including the lack of access to sanitation 
facilities and safe water usually present in this region of the country. Sanitation 
conditions are determinant factors for cystoisosporiasis incidence and 
permanence.
The patient’s poor adherence to HAART is an issue of concern. Irregular 
administration of HAART in patients living with HIV not only reduces 
the likelihood of optimal viral suppression but also increases the risk of 
opportunistic infections such as cystoisosporiasis. Therefore, adherence to 
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treatment has become crucial in the clinical and public health management 
of HIV infection (19). Unfortunately, adverse drug reactions are one of the 
main causes for HAART discontinuation; several adverse effects related to 
the HAART drug cocktail components are known, among them protease 
inhibitors (19). Initially, gastrointestinal symptoms in our patient were thought 
to be related to the HAART therapy, but parasitological analysis confirmed the 
infectious etiology of the syndrome detecting C. belli oocysts in his stool.
Cystoisospora belli chronicity could be related to infection persistence 
possibly associated with the reactivation of the tissue cysts formed by the 
parasite in extra-intestinal organs or in the lamina propria of the intestine (3). 
Cystoisosporiasis recurrences are increasingly observed in patients living with 
HIV/AIDS, particularly in those who do not respond properly to the treatment 
(20). The standard treatment for C. belli infection is oral trimethoprim-
sulfamethoxazole for 7 to 10 days in immunocompetent patients; however, 
immunosuppressed patients usually need longer treatment schedules or 
high doses, as well as maintenance therapy with cotrimoxazole to prevent 
relapses, which occur in nearly 50% of patients following discontinuation of 
initial therapy (21). 
In this case, the patient recovered from the symptoms and responded well 
to the treatment administered after the parasitological diagnosis. Persistent 
infection was most likely due to the absence of an effective treatment given 
the late detection of C. belli. One of the major problems associated with the 
diagnosis of intestinal parasites, including C. belli, is the intermittent shedding 
of their oocyst in the feces favoring false-negative results. Generally, multiple 
samples collected on non-consecutive days improve the sensitivity of the 
direct parasitological analysis (21).
Conclusion
Although cystoisosporiasis is considered a rare condition, it should 
be considered in the differential diagnosis of chronic diarrhea in 
immunosuppressed individuals, especially HIV/AIDS patients from tropical 
and subtropical regions. This report addresses the importance of a correct 
and timely parasite diagnosis to improve patients’ outcomes. Laboratory 
technicians must be trained on parasite identification and the factors that 
improve the sensitivity of diagnostic techniques. Finally, the availability of 
parasite DNA will allow us to carry out future molecular studies regarding 
species confirmation and parasite’s genetic diversity in our population thus 
contributing to the knowledge of its biology.
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